Concepedia

Eric R. Olson

ER

Statistics

Publications

40

Citations

6.9K

H-Index

32

Active since

1982

Affiliations

Vertex Pharmaceuticals (United States)(Current)

University of Michigan

W.E. Upjohn Institute for Employment Research

Stanford University

University of Washington

Eric R. Olson is an author at Vertex Pharmaceuticals (United States) specializing in medicine, microbiology, and molecular biology.

ORCID

Top concepts

Publications per year

1982–2022

40

Publications

40

Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770

Fredrick Van Goor, Sabine Hadidaꝉ, Peter D. J. Grootenhuis et al. · Proceedings of the National Academy of Sciences · 2009 · 1.2K citations · Full text

, , +15

Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809

Fredrick Van Goor, Sabine Hadidaꝉ, Peter D. J. Grootenhuis et al. · Proceedings of the National Academy of Sciences · 2011 · 1.1K citations · Full text

Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- <i>CFTR</i> Mutation

Frank J. Accurso, Steven M. Rowe, John P. Clancy et al. · New England Journal of Medicine · 2010 · 798 citations · Full text

Quantitative ChIP-Seq Normalization Reveals Global Modulation of the Epigenome

David A. Orlando, Mei Wei Chen, Victoria E. Brown et al. · Cell Reports · 2014 · 550 citations · Full text

Rescue of ΔF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules

Fredrick Van Goor, Kimberly Straley, Dong Cao et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2006 · 495 citations

1–5 of 40